Dialyzer Market by Type (High-Flux Dialyzer and Low-Flux Dialyzer) and End User (In-Center and Home Dialysis): Global Opportunity Analysis and Industry Forecast, 2018 - 2025
- Published Date: 2020-10-18
- Report ID: 3415
- Pages: 192
-
Format:
The global dialyzer market was valued at $2,810 million in 2017 and is estimated to reach $4,529 million by 2025, registering a CAGR of 6.2 % from 2018 to 2025.
Dialyzers, also known as artificial kidneys, used during hemodialysis are fortified with a wide variety of membranes and within both the cellulosic and synthetic classes. Dialyzers are bifurcated into high-flux dialyzers and low-flux dialyzers. Among these, high-flux dialyzers are preferred while performing hemodialysis, as they are efficient and help remove larger molecules while performing dialysis as compared to the low-flux dialyzer.
The considerable rise in the geriatric population and increase in incidence of renal diseases, especially end stage renal disease (ESRD) are the key factors that contribute toward the growth of the global dialyzer market. Further, increase in funding for improved dialysis products and services, surge in incidence of chronic diseases such as diabetes and hypertension, and shortage of kidneys for transplantation are expected to propel the market growth. Although the dialyzer market continues to grow, certain factors hamper the growth of this market. The high cost procedure of hemodialysis and associated complications such as severe anemia and fluid overload is anticipated to hamper the market growth. On the contrary, technological advancements leading to better adoption and opportunities in emerging economies are anticipated to offer growth opportunities for the global dialyzer market.
The dialyzer market is segmented based on type and region. Based on type, the market is divided into high-flux dialyzer and low-flux dialyzer. Based on end user, the market is bifurcated into in-center dialyzer and home dialyzer. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global dialyzer market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided.
A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the key segments of the industry helps understand the global trends in the dialyzer market.
Key players and their strategies are provided to understand the competitive outlook of the industry.
KEY MARKET SEGMENTS
By Type
High-Flux Dialyzer
Low-Flux Dialyzer
By End User
In -Center Dialyzer
Home Dialyzer
By Region
o North America
U.S.
Canada
Mexico
o Europe
UK
France
Germany
Italy
France
Austria
Russia
Rest of Europe
o Asia-Pacific
Japan
China
India
South Korea
Australia
Thailand
Malaysia
Indonesia
Taiwan
Rest of Asia-Pacific
o LAMEA
Saudi Arabia
South Africa
Brazil
Turkey
Rest of LAMEA
KEY MARKET PLAYERS
Asahi Kasei Corporation
B. Braun Melsungen AG
Baxter International Inc.
Browndove Healthcare (P) Ltd
Bain Medical Equipment
Fresenius Medical Care AG & Co. KGaA
Kawasumi Laboratories Inc.
Nikkiso Co., LTD.
Medtronic Plc. (Bellco),
Jihua Medical Apparatus & Instruments Co., Ltd
Allmed Medical Care Holdings Limited
Weigao Group
Farmasol
China Chengdu Wesley Biotech Co., Ltd
Toray Industries, Inc.
Medica Group
JMS Co. Ltd
Jiangsu Lengthen Life Science and Technology Co., Ltd
Medivators, Inc.
Dialifegroup
Chapter: 1: INTRODUCTION
1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.3.1. List of players profiled in the report
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
Chapter: 2: EXECUTIVE SUMMARY
2.1. Key Findings of the Study
2.2. CXO perspective
Chapter: 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top investment pockets
3.3. Porters five forces analysis
3.4. Market share analysis, 2017
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. Significant surge in the number of ESRD patients
3.5.1.2. Rise in incidence of diabetes and hypertension
3.5.1.3. Shortage of kidneys for transplantation
3.5.2. Restraints
3.5.2.1. Risks and complications associated with dialyzers reuse
3.5.2.2. High cost associated with the hemodialysis
3.5.3. Opportunities
3.5.3.1. Technological advancements leading to better adoption
3.6. Patent Analysis (2016-2018)
3.6.1. Patent analysis, by year
3.7. Clinical Trials for Dialyzers
Chapter: 4: DIALYZER MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. High-flux dialyzer
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Low-Flux Dialyzer
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
Chapter: 5: DIALYZER MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. In-Center Dialysis
5.2.1. Market analysis, by country
5.3. Home Dialysis
5.3.1. Market analysis, by country
Chapter: 6: DIALYZER MARKET BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.2.1. U.S. dialyzer market, by type
6.2.2.2. U.S. dialyzer market, by end user
6.2.2.3. Canada dialyzer market, by type
6.2.2.4. Canada dialyzer market, by end user
6.2.2.5. Mexico dialyzer market, by type
6.2.2.6. Mexico dialyzer market, by end user
6.2.3. North America dialyzer market, by type
6.2.4. North America dialyzer market, by end user
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.2.1. Germany dialyzer market, by type
6.3.2.2. Germany dialyzer market, by end user
6.3.2.3. France dialyzer market, by type
6.3.2.4. France dialyzer market, by end user
6.3.2.5. UK dialyzer market, by type
6.3.2.6. UK dialyzer market, by end user
6.3.2.7. Italy dialyzer market, by type
6.3.2.8. Italy dialyzer market, by end user
6.3.2.9. Spain dialyzer market, by type
6.3.2.10. Spain dialyzer market, by end user
6.3.2.11. Russia dialyzer market, by type
6.3.2.12. Russia dialyzer market, by end user
6.3.2.13. Austria dialyzer market, by type
6.3.2.14. Austria dialyzer market, by end user
6.3.2.15. Rest of Europe dialyzer market, by type
6.3.2.16. Rest of Europe dialyzer market, by end user
6.3.3. Europe dialyzer market, by type
6.3.4. Europe dialyzer market, by end user
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Market size and forecast, by country
6.4.2.1. Japan dialyzer market, by type
6.4.2.2. Japan dialyzer market, by end user
6.4.2.3. China dialyzer market, by type
6.4.2.4. China dialyzer market, by end user
6.4.2.5. India dialyzer market, by type
6.4.2.6. India dialyzer market, by end user
6.4.2.7. Australia dialyzer market, by type
6.4.2.8. Australia dialyzer market, by end user
6.4.2.9. South Korea dialyzer market, by type
6.4.2.10. South Korea dialyzer market, by end user
6.4.2.11. Taiwan dialyzer market, by type
6.4.2.12. Taiwan dialyzer market, by end user
6.4.2.13. Thailand dialyzer market, by type
6.4.2.14. Thailand dialyzer market, by end user
6.4.2.15. Malaysia dialyzer market, by type
6.4.2.16. Malaysia dialyzer market, by end user
6.4.2.17. Indonesia dialyzer market, by type
6.4.2.18. Indonesia dialyzer market, by end user
6.4.2.19. Rest of Asia-Pacific dialyzer market, by type
6.4.2.20. Rest of Asia-Pacific dialyzer market, by end user
6.4.3. Asia-Pacific dialyzer market, by type
6.4.4. Asia-Pacific dialyzer market, by end user
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil dialyzer market, by type
6.5.2.2. Brazil dialyzer market, by end user
6.5.2.3. Saudi Arabia dialyzer market, by type
6.5.2.4. Saudi Arabia dialyzer market, by end user
6.5.2.5. South Africa dialyzer market, by type
6.5.2.6. South Africa dialyzer market, by end user
6.5.2.7. Turkey dialyzer market, by type
6.5.2.8. Turkey dialyzer market, by end user
6.5.2.9. Rest of LAMEA dialyzer market, by type
6.5.2.10. Rest of LAMEA dialyzer market, by end user
6.5.3. LAMEA dialyzer market, by type
6.5.4. LAMEA dialyzer market, by end user
Chapter: 7: COMPANY PROFILES
7.1. ASAHI KASEI CORPORATION
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product Portfolio
7.1.5. Business performance
7.2. B. BRAUN MELSUNGEN AG
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product Portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. BAXTER INTERNATIONAL INC.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product Portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. BROWNDOVE HEALTHCARE (P) LTD.
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.5. BAIN MEDICAL EQUIPMENT
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Product Portfolio
7.6. FRESENIUS MEDICAL CARE AG & CO. KGAA
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product Portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. KAWASUMI LABORATORIES INC.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segment
7.7.4. Product Portfolio
7.7.5. Business performance
7.8. MEDTRONIC PLC. (BELCO)
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. NIKKISO CO., LTD.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5. Business performance
7.10. JIHUA MEDICAL APPARATUS & INSTRUMENTS CO., LTD
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product Portfolio
7.11. ALLMED MEDICAL CARE HOLDINGS LIMITED
7.11.1. Company overview
7.11.2. Company snapshot
7.11.3. Operating business segments
7.11.4. Product Portfolio
7.12. WEIGAO GROUP
7.12.1. Company overview
7.12.2. Company snapshot
7.12.3. Operating business segments
7.12.4. Product Portfolio
7.12.5. Business performance
7.13. FARMASOL
7.13.1. Company overview
7.13.2. Company snapshot
7.13.3. Operating business segments
7.13.4. Product Portfolio
7.14. CHINA CHENGDU WESLEY BIOTECH CO., LTD
7.14.1. Company overview
7.14.2. Company snapshot
7.14.3. Operating business segments
7.14.4. Product Portfolio
7.15. TORAY INDUSTRIES, INC.
7.15.1. Company overview
7.15.2. Company snapshot
7.15.3. Operating business segments
7.15.4. Product Portfolio
7.15.5. Business performance
7.16. MEDICA GROUP
7.16.1. Company overview
7.16.2. Company snapshot
7.16.3. Operating business segments
7.16.4. Product Portfolio
7.17. JMS CO. LTD.
7.17.1. Company overview
7.17.2. Company snapshot
7.17.3. Operating business segments
7.17.4. Product Portfolio
7.17.5. Business performance
7.18. JIANGSU LENGTHEN LIFE SCIENCE AND TECHNOLOGY CO., LTD
7.18.1. Company overview
7.18.2. Company snapshot
7.18.3. Operating business segments
7.18.4. Product Portfolio
7.19. MEDIVATORS, INC.
7.19.1. Company overview
7.19.2. Company snapshot
7.19.3. Operating business segments
7.19.4. Product Portfolio
7.20. DIALIFEGROUP.COM
7.20.1. Company overview
7.20.2. Company snapshot
7.20.3. Operating business segments
7.20.4. Product Portfolio
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
